Mirati Ther Stock EBITDA
Mirati Ther fundamentals help investors to digest information that contributes to Mirati Ther's financial success or failures. It also enables traders to predict the movement of Mirati Stock. The fundamental analysis module provides a way to measure Mirati Ther's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mirati Ther stock.
Mirati |
Mirati Ther Company EBITDA Analysis
Mirati Ther's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Mirati Ther EBITDA | (759.59 M) |
Most of Mirati Ther's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mirati Ther is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Mirati Ther reported earnings before interest,tax, depreciation and amortization of (759.59 Million). This is 186.57% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 119.48% higher than that of the company.
Mirati EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mirati Ther's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mirati Ther could also be used in its relative valuation, which is a method of valuing Mirati Ther by comparing valuation metrics of similar companies.Mirati Ther is currently under evaluation in ebitda category among its peers.
Mirati Fundamentals
| Return On Equity | -0.7 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (10.49) % | |||
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 70.15 M | |||
| Shares Owned By Insiders | 1.72 % | |||
| Shares Owned By Institutions | 98.28 % | |||
| Number Of Shares Shorted | 4.39 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 4.35 X | |||
| Price To Sales | 107.82 X | |||
| Revenue | 12.44 M | |||
| Gross Profit | (519.79 M) | |||
| EBITDA | (759.59 M) | |||
| Net Income | (740.87 M) | |||
| Cash And Equivalents | 1.19 B | |||
| Cash Per Share | 21.41 X | |||
| Total Debt | 51.51 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 10.10 X | |||
| Book Value Per Share | 13.50 X | |||
| Cash Flow From Operations | (570.57 M) | |||
| Short Ratio | 2.88 X | |||
| Earnings Per Share | (12.18) X | |||
| Target Price | 61.2 | |||
| Number Of Employees | 587 | |||
| Beta | 0.77 | |||
| Market Capitalization | 4.12 B | |||
| Total Asset | 1.2 B | |||
| Retained Earnings | (2.45 B) | |||
| Working Capital | 949.51 M | |||
| Current Asset | 125.4 M | |||
| Current Liabilities | 9.8 M | |||
| Z Score | 43.99 | |||
| Net Asset | 1.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |